Contract HHSN272201301062P
University Of Massachusetts Biologic Labs · Department Of Health And Human Services · September 12, 2013
University Of Massachusetts Biologic Labs was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 12, 2013 for $5,000 of work in biological product (except diagnostic) manufacturing. Performance is in Mattapan, MA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 22, 2013.
Contract details
- PIID
- HHSN272201301062P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals, Veterinary Use
- Place of performance
- Mattapan, MA
- First action
- September 12, 2013
- Latest action
- October 22, 2013
Description
DEPLETING ANTIBODIES CD4&CD8.
Modification timeline
-
October 22, 2013Mod 1$-100
-
September 12, 2013Base award$5.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN272201301062P?
Contract HHSN272201301062P is a federal contract awarded to University Of Massachusetts Biologic Labs by Department Of Health And Human Services on September 12, 2013 for $5,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HHSN272201301062P?
University Of Massachusetts Biologic Labs won contract HHSN272201301062P from Department Of Health And Human Services.
How much is contract HHSN272201301062P worth?
Contract HHSN272201301062P has obligated $5,000 to date.